2018
DOI: 10.3390/nu10060775
|View full text |Cite
|
Sign up to set email alerts
|

The Role of n-3 Long Chain Polyunsaturated Fatty Acids in Cardiovascular Disease Prevention, and Interactions with Statins

Abstract: Decreases in global cardiovascular disease (CVD) mortality and morbidity in recent decades can be partly attributed to cholesterol reduction through statin use. n-3 long chain polyunsaturated fatty acids are recommended by some authorities for primary and secondary CVD prevention, and for triglyceride reduction. The residual risk of CVD that remains after statin therapy may potentially be reduced by n-3 long chain polyunsaturated fatty acids. However, the effects of concomitant use of statins and n-3 long chai… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
53
0
1

Year Published

2018
2018
2021
2021

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 61 publications
(55 citation statements)
references
References 90 publications
(123 reference statements)
1
53
0
1
Order By: Relevance
“…n-3 polyunsaturated fatty acids and n-6 polyunsaturated fatty acids is indispensable fatty acid for human(39). It is well known that a lower n6/n3 ratio is better according to the guidelines of the WHO regarding healthy food for humans (26).…”
Section: Discussionmentioning
confidence: 99%
“…n-3 polyunsaturated fatty acids and n-6 polyunsaturated fatty acids is indispensable fatty acid for human(39). It is well known that a lower n6/n3 ratio is better according to the guidelines of the WHO regarding healthy food for humans (26).…”
Section: Discussionmentioning
confidence: 99%
“…Although EPA and DHA share many biological effects, some differences have been reported. 54,55 The ongoing STRENGTH trial (NCT02104817), which uses a combination of EPA and DHA, may help to clarify the roles of omega-3 PUFAs for secondary prevention of CV events. 82 Although more detailed analyses are needed, the currently available analyses support the conclusion that TG lowering is not the sole mechanism responsible for lowering CV risk among the patients who participated in REDUCE-IT.…”
Section: Was Reduce-it Different?mentioning
confidence: 91%
“…Reported biological actions of EPA and DHA extend well beyond TG lowering and include effects expected to be cardioprotective . As summarized by Mozaffarian and Rimm, and shown in Figure , fish oil omega‐3 PUFAs have been linked with reduced blood pressure and heart rate, as well as decreased platelet aggregation .…”
Section: Residual Riskmentioning
confidence: 97%
See 1 more Smart Citation
“…On the other hand, the properties of some dietary fatty acids have been studied in relation to vascular health, especially n‐3 polyunsaturated fatty acids, which have exhibited cardioprotective effects . In recent years it has been suggested that some isomers of linoleic acid could have beneficial effects on human health, associated with CVD .…”
Section: Introductionmentioning
confidence: 99%